Dose Dense Chemotherapy With Lipegfilgrastim Support in Early Breast Cancer
Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
This is a prospective, non-interventional, single arm study, which is examining doxorubicin
and cyclophosphamide (AC) once every 2 weeks with lipegfilgrastim support in early breast
cancer.